Home Featured Page 166

Featured

Latest

Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

PT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere

COMPASS Pathways partners with One Mind to fund Rising Star Awards...

Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application...

PT311 – William Leonard Pickard – LSD, Fentanyl, Prison, and the...

Psychedelic Bulletin: Numinus to Enter U.S. Clinics Market; Mydecine Announces Reverse...

MindMed Collaborator Dr. Matthias Liechti to Present Topline Clinical Trial Results...

Filament Health Is Issued Patent By United States Patent And Trademark...

Cybin Announces Publication of International PCT Patent Application for Inhalation Delivery...

Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy...

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Formulation and Production...

1...165166167...296 Page 166 of 296

Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

PT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere

COMPASS Pathways partners with One Mind to fund Rising Star Awards...

Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application...

PT311 – William Leonard Pickard – LSD, Fentanyl, Prison, and the...

Psychedelic Bulletin: Numinus to Enter U.S. Clinics Market; Mydecine Announces Reverse...

MindMed Collaborator Dr. Matthias Liechti to Present Topline Clinical Trial Results...

Filament Health Is Issued Patent By United States Patent And Trademark...

Cybin Announces Publication of International PCT Patent Application for Inhalation Delivery...

Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy...

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Formulation and Production...

EDITOR PICKS

Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY